APO RESEARCH · REPORT
Transcriptomics
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Product & engineering
Understand the product.
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
Selected research
Market Structure
Global Transcriptomics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
North America is the largest consumption place, with a consumption market share nearly 55% . Following North America, Europe is the second largest consumption place with the consumption market share of 25% .The key manufacturers are Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories, Fluidigm etc. Top 3 companies occupied about 41% market share.
Report Includes
Read the full market overview
This report provides an overview of the global Transcriptomics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Transcriptomics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Transcriptomics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Transcriptomics market size, projected growth trends, production technologies, key applications, and end-use industries.
Transcriptomics Segment by Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Transcriptomics Segment by Type
PCR
Microarray
Sequencing
Transcriptomics Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
Transcriptomics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcriptomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transcriptomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcriptomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Transcriptomics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transcriptomics industry.
Chapter 3: Detailed analysis of Transcriptomics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Transcriptomicsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PCR
- Microarray
- Sequencing
Applications
- Pharmaceutical and Biotechnology
- Academic Research and Government Institutes
- Hospitals and Diagnostic Centers
Companies covered
- Thermo Fisher Scientific
- Illumina
- QIAGEN (Exiqon)
- Agilent Technologies
- Roche
- GE Healthcare
- Bio-Rad Laboratories
- Fluidigm
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Transcriptomics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 PCR
- 1.2.3 Microarray
- 1.2.4 Sequencing
- 1.3 Market Analysis by Application
- 1.3.1 Global Transcriptomics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotechnology
- 1.3.3 Academic Research and Government Institutes
- 1.3.4 Hospitals and Diagnostic Centers
- 1.4 Global Market Growth Prospects
- 1.5 Global Transcriptomics Growth Trends by Region
- 1.5.1 Global Transcriptomics Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Transcriptomics Market Size by Region (2021-2026)
- 1.5.3 Transcriptomics Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Transcriptomics Market Dynamics
- 2.1 Transcriptomics Industry Trends
- 2.2 Transcriptomics Industry Drivers
- 2.3 Transcriptomics Industry Opportunities and Challenges
- 2.4 Transcriptomics Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Transcriptomics Revenue by Company (2021-2026)
- 3.2 Global Transcriptomics Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Transcriptomics Key Company Head office and Area Served
- 3.4 Global Transcriptomics Company, Product Type & Application
- 3.5 Global Transcriptomics Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Transcriptomics Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Transcriptomics Players Market Share by Revenue in 2025
- 3.6.3 2025 Transcriptomics Tier 1, Tier 2, and Tier 3
4 Transcriptomics Market by Type
- 4.1 Global Transcriptomics Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Transcriptomics Market Size by Type (2021-2032)
- 4.3 Global Transcriptomics Market Size Share by Type (2021-2032)
5 Transcriptomics Market by Application
- 5.1 Global Transcriptomics Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Transcriptomics Market Size by Application (2021-2032)
- 5.3 Global Transcriptomics Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thermo Fisher Scientific
- 6.1.1 Thermo Fisher Scientific Company Information
- 6.1.2 Thermo Fisher Scientific Business Overview
- 6.1.3 Thermo Fisher Scientific Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thermo Fisher Scientific Transcriptomics Product Portfolio
- 6.1.5 Thermo Fisher Scientific Recent Developments
- 6.2 Illumina
- 6.2.1 Illumina Company Information
- 6.2.2 Illumina Business Overview
- 6.2.3 Illumina Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Illumina Transcriptomics Product Portfolio
- 6.2.5 Illumina Recent Developments
- 6.3 QIAGEN (Exiqon)
- 6.3.1 QIAGEN (Exiqon) Company Information
- 6.3.2 QIAGEN (Exiqon) Business Overview
- 6.3.3 QIAGEN (Exiqon) Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 QIAGEN (Exiqon) Transcriptomics Product Portfolio
- 6.3.5 QIAGEN (Exiqon) Recent Developments
- 6.4 Agilent Technologies
- 6.4.1 Agilent Technologies Company Information
- 6.4.2 Agilent Technologies Business Overview
- 6.4.3 Agilent Technologies Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Agilent Technologies Transcriptomics Product Portfolio
- 6.4.5 Agilent Technologies Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Roche Transcriptomics Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 GE Healthcare
- 6.6.1 GE Healthcare Company Information
- 6.6.2 GE Healthcare Business Overview
- 6.6.3 GE Healthcare Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GE Healthcare Transcriptomics Product Portfolio
- 6.6.5 GE Healthcare Recent Developments
- 6.7 Bio-Rad Laboratories
- 6.7.1 Bio-Rad Laboratories Company Information
- 6.7.2 Bio-Rad Laboratories Business Overview
- 6.7.3 Bio-Rad Laboratories Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Bio-Rad Laboratories Transcriptomics Product Portfolio
- 6.7.5 Bio-Rad Laboratories Recent Developments
- 6.8 Fluidigm
- 6.8.1 Fluidigm Company Information
- 6.8.2 Fluidigm Business Overview
- 6.8.3 Fluidigm Transcriptomics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Fluidigm Transcriptomics Product Portfolio
- 6.8.5 Fluidigm Recent Developments
7 North America
- 7.1 North America Transcriptomics Market Size (2021-2032)
- 7.2 North America Transcriptomics Market Size by Type
- 7.2.1 North America Transcriptomics Market Size by Type (2021-2026)
- 7.2.2 North America Transcriptomics Market Size by Type (2027-2032)
- 7.2.3 North America Transcriptomics Market Share by Type (2021-2032)
- 7.3 North America Transcriptomics Market Size by Application
- 7.3.1 North America Transcriptomics Market Size by Application (2021-2026)
- 7.3.2 North America Transcriptomics Market Size by Application (2027-2032)
- 7.3.3 North America Transcriptomics Market Share by Application (2021-2032)
- 7.4 North America Transcriptomics Market Size by Country
- 7.4.1 North America Transcriptomics Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Transcriptomics Market Size by Country (2021-2026)
- 7.4.3 North America Transcriptomics Market Size by Country (2027-2032)
- 7.4.4 North America Transcriptomics Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Transcriptomics Market Size (2021-2032)
- 8.2 Europe Transcriptomics Market Size by Type
- 8.2.1 Europe Transcriptomics Market Size by Type (2021-2026)
- 8.2.2 Europe Transcriptomics Market Size by Type (2027-2032)
- 8.2.3 Europe Transcriptomics Market Share by Type (2021-2032)
- 8.3 Europe Transcriptomics Market Size by Application
- 8.3.1 Europe Transcriptomics Market Size by Application (2021-2026)
- 8.3.2 Europe Transcriptomics Market Size by Application (2027-2032)
- 8.3.3 Europe Transcriptomics Market Share by Application (2021-2032)
- 8.4 Europe Transcriptomics Market Size by Country
- 8.4.1 Europe Transcriptomics Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Transcriptomics Market Size by Country (2021-2026)
- 8.4.3 Europe Transcriptomics Market Size by Country (2027-2032)
- 8.4.4 Europe Transcriptomics Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Transcriptomics Market Size (2021-2032)
- 9.2 China Transcriptomics Market Size by Type
- 9.2.1 China Transcriptomics Market Size by Type (2021-2026)
- 9.2.2 China Transcriptomics Market Size by Type (2027-2032)
- 9.2.3 China Transcriptomics Market Share by Type (2021-2032)
- 9.3 China Transcriptomics Market Size by Application
- 9.3.1 China Transcriptomics Market Size by Application (2021-2026)
- 9.3.2 China Transcriptomics Market Size by Application (2027-2032)
- 9.3.3 China Transcriptomics Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Transcriptomics Market Size (2021-2032)
- 10.2 Asia Transcriptomics Market Size by Type
- 10.2.1 Asia Transcriptomics Market Size by Type (2021-2026)
- 10.2.2 Asia Transcriptomics Market Size by Type (2027-2032)
- 10.2.3 Asia Transcriptomics Market Share by Type (2021-2032)
- 10.3 Asia Transcriptomics Market Size by Application
- 10.3.1 Asia Transcriptomics Market Size by Application (2021-2026)
- 10.3.2 Asia Transcriptomics Market Size by Application (2027-2032)
- 10.3.3 Asia Transcriptomics Market Share by Application (2021-2032)
- 10.4 Asia Transcriptomics Market Size by Country
- 10.4.1 Asia Transcriptomics Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Transcriptomics Market Size by Country (2021-2026)
- 10.4.3 Asia Transcriptomics Market Size by Country (2027-2032)
- 10.4.4 Asia Transcriptomics Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Transcriptomics Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Transcriptomics Market Size by Type
- 11.2.1 South America, Middle East & Africa Transcriptomics Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Transcriptomics Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Transcriptomics Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Transcriptomics Market Size by Application
- 11.3.1 South America, Middle East & Africa Transcriptomics Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Transcriptomics Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Transcriptomics Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Transcriptomics Market Size by Country
- 11.4.1 South America, Middle East & Africa Transcriptomics Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Transcriptomics Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Transcriptomics Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Transcriptomics Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst